Blog – Page 6 – CE Dojo

Q: Are your courses approved for CE by the Board?

CE Dojo is certified as a national provider of continuing education (CE) through the Academy of General Dentistry's (AGD) Program Approval For Continuing Education (PACE). Most state regulatory agencies recognize AGD PACE programs as legitimate sources for continuing education. We suggest you contact your specific state regulatory agency for further clarification if necessary.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

Leave a Comment / Opiate Crisis, Regulatory Compliance / By David Lambert

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners Read More »

FDA Approves OTC Naloxone

Leave a Comment / Opiate Crisis, Regulatory Compliance / By David Lambert

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA

FDA Approves OTC Naloxone Read More »

Update: MATE Act

Leave a Comment / Opiate Crisis, Regulatory Compliance / By David Lambert

The ADA has issued a FAQ (frequently asked questions) providing additional information regarding the 2022 Omnibus Bill with provisions for the MATE Act – which included a controlled substance education requirement for continuing DEA registration. The FAQ suggests further information and guidance will be forthcoming by the end of March. The Act contains exclusions and

Update: MATE Act Read More »

MATE Act

Leave a Comment / Opiate Crisis, Regulatory Compliance / By David Lambert

It has come to our attention a little known provision of the federal omnibus bill approved in the waning hours of 2022 included a requirement that could impact your practice if not properly managed. The Medication Access and Training Expansion (MATE) Act, which aims to improve access to medications and expand training for healthcare professionals

MATE Act Read More »

Antihistamines A common Contributor In Opioid Overdose Deaths?

Leave a Comment / Opiate Crisis / By David Lambert

A recent CDC analysis shows that antihistamines, particularly first-generation H1 subtype antihistamines like diphenhydramine, play a role in drug overdoses. Opioids were involved in most cases, and naloxone may not work with antihistamines. Continual monitoring is important.

Antihistamines A common Contributor In Opioid Overdose Deaths? Read More »

Must Read…

Leave a Comment / Practice Management / By David Lambert

Discover the greatest sage wisdom through a must-read book. Purchase it and start putting it into practice today.

Must Read… Read More »

FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs

Leave a Comment / Opiate Crisis / By David Lambert

Healthcare professionals have been alerted by the FDA to the dangers of patients being exposed to xylazine, a veterinary sedative, in illicit drugs. The FDA advises healthcare professionals to report any adverse events related to xylazine.

FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs Read More »

NC Policy Watch – A closer look at the mounting toll of fentanyl on the nation’s youth

Leave a Comment / Opiate Crisis / By David Lambert

Fentanyl is now the leading cause of overdose deaths among young people, with a nearly 500% increase in deaths among those aged 25 and under. Learn more.

NC Policy Watch – A closer look at the mounting toll of fentanyl on the nation’s youth Read More »

FDA Modernization Act 2.0

Leave a Comment / Drug Safety & Efficacy / By David Lambert

Congress has passed the FDA Modernization Act 2.0 as part of the recent omnibus bill, removing the requirement to use animal testing in drug development. This allows drug companies to use alternative safety-testing models, such as cell-based assays, organ chips and microphysiological systems, and sophisticated computer modeling. Proponents state these alternatives are cost-effective and provide

FDA Modernization Act 2.0 Read More »

The Fourth Wave Of The Opiate Crisis

Leave a Comment / Opiate Crisis / By David Lambert

For over two decades, the opioid crisis in the United States has been an urgent health care emergency. Initially driven by over-prescription of pharmaceutical opioids, this has evolved into a “fourth wave” marked by poly-substance use, combining opioids and methamphetamine, resulting in record-high deaths year after year. The Covid-19 pandemic has made the situation even

The Fourth Wave Of The Opiate Crisis Read More »

Popular FAQs

Administrative

Are your courses approved for CE by the Board?

Category: Administrative

CE Dojo is certified as a national provider of continuing education (CE) through the Academy of General Dentistry’s (AGD) Program Approval For Continuing Education (PACE). Most state regulatory agencies recognize AGD PACE programs as legitimate sources for continuing education. We suggest you contact your specific state regulatory agency for further clarification if necessary.

Did you find this FAQ helpful?

Getting Started

Ok, I paid my registration fee. What do I do now?

Category: Getting Started

Once you have paid your course registration fee, you will be able to access your course after you sign-in to your user account…which you just created. But you need a password!

Did you receive these emails?

A transaction receipt
A course confirmation
General User Instructions
Log-in details
And possibly others…

Are those emails in your “Inbox”? If not, check your spam folder. If they are in your spam folder, your email provider (or domain) is filtering messages from ce-dojo.com. If your registration emails from CE Dojo are being sent to spam, see our FAQ “I can’t find any emails from CE Dojo!!”.

One email provides you with log-in details you specified during registration. But, it will also prompt you with a link to set your password. When complete, these two credentials – user name and password – will provide access to your “account”. Write these down. If you forget your password, you can reset it yourself – see our FAQ “I forgot the password to my CE Dojo user account!”

Now that you have your password in hand, you can log into your account to access your course(s).

Did you find this FAQ helpful?

I can’t find any emails from CE Dojo!!

Category: Getting Started

Often times email services (Google, etc) will filter email away from your inbox. Did you check your spam folder? But, simply moving our email out of spam to your inbox will NOT prevent future emails from meeting the same demise. The solution is to add email addresses from CE Dojo to your contact list.

If you do not find any email communications from CE Dojo in any of your email folders – including spam – there is a very real possibility your internet service provider (ISP) may have a firewall that is blocking our email. We have found that even adding our email addresses to your contact list does not resolve this problem. We have identified a couple of problem ISPs:

RoadRunner (nc.rr.com)
Apple (iCloud.com)
Embarq
Frontier
HughesNet
And others…

In this case, there is no resolution to this problem other than to create a “free email” account with Gmail, YahooMail, Hotmail, etc. Provide CE Dojo with your new email address and we’ll update our records. Again, don’t forget to add us to your contact list!

Did you find this FAQ helpful?